Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
Arno Nierich, Anaesthesiologist and Intensivist specializing in cardiac surgery at Isala Hospital, shared a post on LinkedIn:
”Caffeine, a non-selective antagonist of the ADORA2B receptor found on red blood cells (RBCs), appears to interfere with key metabolic and hypoxic responses, including glycolysis and 2,3-BPG synthesis, both essential for oxygen delivery under stress.
These findings suggest that caffeine may compromise ATP production and increase hemolysis during storage.
Why This Matters for Innovation in Blood Transfusion
By enabling autologous blood recovery and bedside reinfusion, HemoClear supports PBM strategies that eliminate the need for extended storage, thereby avoiding biochemical degradation risks linked to factors like caffeine exposure.
As we deepen our understanding of how lifestyle and genetics influence transfusion outcomes, it’s also time to rethink how we approach blood safety, quality, and innovation.”
Find more information here.
Stay updated with Hemostasis Today.
-
Aug 20, 2026, 01:23Jessica Erley: Understanding Patient Experience Beyond the Clinical Encounter
-
Aug 20, 2026, 01:19Dries De Wolf: Innovative Gene Therapy for Hemophilia B
-
Aug 19, 2026, 19:09Gregory Lip: PFO Closure in Younger Patients With Cryptogenic Stroke
-
Aug 19, 2026, 18:51Filippo Crea: AF and Alzheimer’s Disease – Does the Anticoagulant Choice Matter for the Brain?
-
Aug 19, 2026, 18:42Alan Nurden: How Procoagulant Platelets Relate to Microparticle Release?
-
Aug 19, 2026, 18:25Ivan Centeno Sáenz: FeNO and Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
-
Aug 19, 2026, 18:10Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care and Access to Treatment in Fiji
-
Aug 19, 2026, 17:58Paulomi Ghosh: Delighted to Deliver a Talk on Hemostasis and Hemorrhage Control
-
Aug 19, 2026, 17:34Ryan O’Keefe: Clopidogrel Non-Responders and the Risk of Stent Thrombosis